144 related articles for article (PubMed ID: 37586438)
1. Therapeutic targeting of HYPDH/PRODH2 with N-propargylglycine offers a Hyperoxaluria treatment opportunity.
Bons J; Tadeo A; Scott GK; Teramayi F; Tanner JJ; Schilling B; Benz CC; Ellerby LM
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166848. PubMed ID: 37586438
[TBL] [Abstract][Full Text] [Related]
2. The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.
Buchalski B; Wood KD; Challa A; Fargue S; Holmes RP; Lowther WT; Knight J
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165633. PubMed ID: 31821850
[TBL] [Abstract][Full Text] [Related]
3. Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria.
Summitt CB; Johnson LC; Jönsson TJ; Parsonage D; Holmes RP; Lowther WT
Biochem J; 2015 Mar; 466(2):273-81. PubMed ID: 25697095
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria.
Jiang J; Johnson LC; Knight J; Callahan MF; Riedel TJ; Holmes RP; Lowther WT
Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(6):G637-43. PubMed ID: 22207577
[TBL] [Abstract][Full Text] [Related]
5. Brain transcriptomic, metabolic and mitohormesis properties associated with N-propargylglycine treatment: A prevention strategy against neurodegeneration.
Teramayi F; Bons J; Scott M; Scott GK; Loureiro A; Lopez-Ramirez A; Schilling B; Ellerby LM; Benz CC
Brain Res; 2024 Mar; 1826():148733. PubMed ID: 38128812
[TBL] [Abstract][Full Text] [Related]
6. A new metabolite of propargylglycine, gamma-glutamylpropargylglycylglycine, in liver of D,L-propargylglycine-administered rats.
Ohta J; Ubuka T; Kodama H; Sugahara K; Nagamine N
Biochim Biophys Acta; 1997 Mar; 1334(2-3):240-6. PubMed ID: 9101719
[TBL] [Abstract][Full Text] [Related]
7. N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties.
Scott GK; Mahoney S; Scott M; Loureiro A; Lopez-Ramirez A; Tanner JJ; Ellerby LM; Benz CC
Amino Acids; 2021 Dec; 53(12):1927-1939. PubMed ID: 34089390
[TBL] [Abstract][Full Text] [Related]
8. Genetic cause and prevalence of hydroxyprolinemia.
Staufner C; Haack TB; Feyh P; Gramer G; Raga DE; Terrile C; Sauer S; Okun JG; Fang-Hoffmann J; Mayatepek E; Prokisch H; Hoffmann GF; Kölker S
J Inherit Metab Dis; 2016 Sep; 39(5):625-632. PubMed ID: 27139199
[TBL] [Abstract][Full Text] [Related]
9. Formation of gamma-glutamylpropargylglycylglycine from propargylglycine in human blood and erythrocytes.
Nagamine N; Ohta J; Masuoka N; Kodama H; Ubuka T
Acta Med Okayama; 1999 Feb; 53(1):19-25. PubMed ID: 10096734
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.
Li X; Knight J; Fargue S; Buchalski B; Guan Z; Inscho EW; Liebow A; Fitzgerald K; Querbes W; Todd Lowther W; Holmes RP
Biochim Biophys Acta; 2016 Feb; 1862(2):233-9. PubMed ID: 26655602
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of cystathionine, N-monoacetylcystathionine, perhydro-1,4-thiazepine-3,5-dicarboxylic acid, and cystathionine ketimine in the liver and kidney of D,L-propargylglycine-treated rats.
Zhang J; Zhang M; Ma D; Sugahara K; Kodama H
Metabolism; 1998 Oct; 47(10):1233-8. PubMed ID: 9781627
[TBL] [Abstract][Full Text] [Related]
12. Lipid peroxidation is not the underlying cause of renal injury in hyperoxaluric rats.
Green ML; Freel RW; Hatch M
Kidney Int; 2005 Dec; 68(6):2629-38. PubMed ID: 16316339
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.
Fargue S; Milliner DS; Knight J; Olson JB; Lowther WT; Holmes RP
J Am Soc Nephrol; 2018 Jun; 29(6):1615-1623. PubMed ID: 29588429
[No Abstract] [Full Text] [Related]
14. Nephrotoxicity of D-proparglyglycine in mice.
Konno R; Ikeda M; Yamaguchi K; Ueda Y; Niwa A
Arch Toxicol; 2000 Oct; 74(8):473-9. PubMed ID: 11097385
[TBL] [Abstract][Full Text] [Related]
15. Propargylglycine infusion effects on tissue glutathione levels, plasma amino acid concentrations and tissue morphology in parenterally-fed growing rats.
Cho ES; Hovanec-Brown J; Tomanek RJ; Stegink LD
J Nutr; 1991 Jun; 121(6):785-94. PubMed ID: 2033464
[TBL] [Abstract][Full Text] [Related]
16. Improved methodology to induce hyperoxaluria without treatment using hydroxyproline.
Wiessner JH; Garrett MR; Hung LY; Wille DF; Mandel NS
Urol Res; 2011 Oct; 39(5):373-7. PubMed ID: 21373921
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Hydroxy-L-proline (HYP) analogs in the treatment of primary hyperoxaluria in Drosophila Melanogaster.
Yang H; Male M; Li Y; Wang N; Zhao C; Jin S; Hu J; Chen Z; Ye Z; Xu H
BMC Nephrol; 2018 Jul; 19(1):167. PubMed ID: 29980178
[TBL] [Abstract][Full Text] [Related]
18. Determination of D,L-propargylglycine and N-acetylpropargylglycine in urine and several tissues of D,L-propargylglycine-treated rats using liquid chromatography-mass spectrometry.
Zhang J; Machida Y; Sugahara K; Kodama H
J Chromatogr B Biomed Appl; 1994 Oct; 660(2):375-9. PubMed ID: 7866528
[TBL] [Abstract][Full Text] [Related]
19. Effect of D,L-propargylglycine on cystathionine metabolism in rats.
Awata S; Nakayama K; Kodama H
Biochem Int; 1984 Jan; 8(1):171-9. PubMed ID: 6477595
[TBL] [Abstract][Full Text] [Related]
20. Hyperoxaluric rats do not exhibit alterations in renal expression patterns of Slc26a1 (SAT1) mRNA or protein.
Freel RW; Hatch M
Urol Res; 2012 Dec; 40(6):647-54. PubMed ID: 22573180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
